APA (7th ed.) Citation

Kelley, M. J., Jha, G., Shoemaker, D., Herndon II, J. E., Gu, L., Barry, W. T., . . . Ready, N. (2017). Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer. Cancer Investigation, 35(1), 32. https://doi.org/10.1080/07357907.2016.1253710

Chicago Style (17th ed.) Citation

Kelley, Michael J., Gautam Jha, Debra Shoemaker, James E. Herndon II, Lin Gu, William T. Barry, Jeffrey Crawford, and Neal Ready. "Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer." Cancer Investigation 35, no. 1 (2017): 32. https://doi.org/10.1080/07357907.2016.1253710.

MLA (9th ed.) Citation

Kelley, Michael J., et al. "Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer." Cancer Investigation, vol. 35, no. 1, 2017, p. 32, https://doi.org/10.1080/07357907.2016.1253710.